• Search History (Register)
  • MeSH Browser

Welcome to the international HTA database


Showing [23378 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2010     Belgian Health Care Knowledge Centre (KCE) [Cost-utility of vaccination against chickenpox in children and against herpes zoster in elderly in Belgium]
2023     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) [Cost-utility analysis of universal neonatal screening for critical congenital heart disease based on pulsioximetry in Spain]
2011     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) [Cost-utility analysis of the introduction of universal infant rotavirus vaccination in Spain]
2010     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) [Cost-utility analysis of pharmacological treatments for the prevention of bone fractures in osteoporotic post-menopausal Spanish women]
2018     Canary Health Service [Cost-effectiveness of vaccination against herpes zoster]
2020     Canary Health Service [Cost-effectiveness of universal childhood vaccination against hepatitis A (update)]
2012     The Netherlands Organisation for Health Research and Development (ZonMw) [Cost-effectiveness of two strategies to implement the NVOG guidelines on hypertension in pregnancy: an innovative strategy including a computerised decision support system compared to a common strategy of professional audit & feedback]
2009     The Netherlands Organisation for Health Research and Development (ZonMw) [Cost-effectiveness of two different strategies to implement the NVOG guideline programme on subfertility]
2012     The Netherlands Organisation for Health Research and Development (ZonMw) [Cost-effectiveness of the demands and capacities model based treatment compared to the Lidcombe programme of early stuttering intervention: randomised trial]
2009     The Netherlands Organisation for Health Research and Development (ZonMw) [Cost-effectiveness of the Australian medical sheepskin for the prevention of pressure ulcers in somatic nursing home clients]
2023     Canary Health Service [Cost-effectiveness of systematic vaccination against invasive meningococcal disease due to serogroup B in childhood]
2006     The Netherlands Organisation for Health Research and Development (ZonMw) [Cost-effectiveness of selecting compatible donor blood in Rhc- and RhE negative females during and before reproductive age to prevent hemolytic disease in the newborn (HDN)]
2017     Canary Health Service [Cost-effectiveness of pneumococcal vaccination in adults older than 60 years]
2014     Basque Office for Health Technology Assessment (OSTEBA) [Cost-effectiveness of percutaneous aortic valve replacement using prosthetic valve versus the standard surgical treatment]
2011     The Netherlands Organisation for Health Research and Development (ZonMw) [Cost-effectiveness of nutritional screening and intervention in elderly subjects after hip fracture]
2023     Canary Health Service [Cost-effectiveness of newborn screening for tyrosinemia type I (update)]
2013     Canary Health Service [Cost-effectiveness of newborn screening for sickle cell anemia]
2008     Canary Health Service [Cost-effectiveness of newborn screening for congenital metabolic disorders using tandem mass spectrometry]
2013     Canary Health Service [Cost-effectiveness of neonatal screening for congenital adrenal hyperplasia]
2013     Canary Health Service [Cost-effectiveness of neonatal screening for classical galactosemia]
2013     Canary Health Service [Cost-effectiveness of neonatal screening for biotinidase deficiency]
2011     The Netherlands Organisation for Health Research and Development (ZonMw) [Cost-effectiveness of monitoring of psychotherapeutic treatments: a randomized comparison on the effects of feedback to therapists and patients in three settings of outpatient psychotherapy]
2019     Canary Health Service [Cost-effectiveness of mechanical thrombectomy for treatment of ischaemic stroke]
2010     Canary Health Service [Cost-effectiveness of knowledge transfer methods]
2010     Canary Health Service [Cost-effectiveness of isolated stenting versus stenting with balloon angioplasty and vascular protection in carotid atherosclerosis]
2011     Canary Health Service [Cost-effectiveness of interventions to prevent and correct childhood obesity]
2011     Canary Health Service [Cost-effectiveness of implantable automatic defibrillator in primary prevention in Spain]
2013     National Evidence-based Healthcare Collaborating Agency (NECA) [Cost-effectiveness of human papillomavirus vaccination in South Korea]
2008     Center for Medical Technology Assessment (CMT) [Cost-effectiveness of hearing aids - linear vs non-linear characteristics]
2011     Canary Health Service [Cost-effectiveness of gastric bypass]
2006     The Netherlands Organisation for Health Research and Development (ZonMw) [Cost-effectiveness of follow-up of patients with superficial bladder cancer]
2010     Canary Health Service [Cost-effectiveness of endovascular treatment versus open surgery in patients with steno-occlusive femoral artery disease]
2008     The Netherlands Organisation for Health Research and Development (ZonMw) [Cost-effectiveness of different strategies for the treatment and monitoring of ocular hypertension and glaucoma]
2008     The Netherlands Organisation for Health Research and Development (ZonMw) [Cost-effectiveness of decision rules for the use of CT for minimal head injury]
2014     National Evidence-based Healthcare Collaborating Agency (NECA) [Cost-effectiveness of conventional cytology and HPV DNA testing for cervical cancer screening in South Korea]
2008     The Netherlands Organisation for Health Research and Development (ZonMw) [Cost-effectiveness of cognitive behaviour therapy for recent onset schizophrenia patients with persistent and recurrent psychosis]
2009     Norwegian Knowledge Centre for the Health Services (NOKC) [Cost-effectiveness of childhood vaccination against rotavirus in Norway]
2023     Canary Health Service [Cost-effectiveness of childhood vaccination against invasive meningococcal disease due to ACWY serogroups]
2010     The Netherlands Organisation for Health Research and Development (ZonMw) [Cost-effectiveness of care for patients with type 2 diabetes, an evaluation of an innovative shared diabetes care model ("Ketenzorg model")]
2007     Center for Medical Technology Assessment (CMT) [Cost-effectiveness of assistive technologies - walkers]
2024     Center for Outcomes Research and Economic Evaluation for Health (C2H) [Cost-effectiveness evaluation of tezepelumab (Tezspire)]
2024     Center for Outcomes Research and Economic Evaluation for Health (C2H) [Cost-effectiveness evaluation of molnupiravir (Lagevrio)]
2023     Center for Outcomes Research and Economic Evaluation for Health (C2H) [Cost-effectiveness evaluation of gefapixant (Lyfnua)]
2024     Center for Outcomes Research and Economic Evaluation for Health (C2H) [Cost-effectiveness evaluation of finerenone (Kerendia)]
2023     Center for Outcomes Research and Economic Evaluation for Health (C2H) [Cost-effectiveness evaluation of Efgartigimod Alfa (Vyvgart)]
2023     Center for Outcomes Research and Economic Evaluation for Health (C2H) [Cost-effectiveness evaluation of clazosentan (Pivlaz)]
2023     Center for Outcomes Research and Economic Evaluation for Health (C2H) [Cost-effectiveness evaluation of bimekizumab (Bimzelx)]
2023     Center for Outcomes Research and Economic Evaluation for Health (C2H) [Cost-effectiveness evaluation of andexanet alfa (Ondexxya)]
2023     Center for Outcomes Research and Economic Evaluation for Health (C2H) [Cost-effectiveness evaluation of andexanet alfa (Ondexxya)]
2001     Basque Office for Health Technology Assessment (OSTEBA) [Cost-effectiveness analysis of treatments of sleep apnea syndrome in the Basque Country]
2010     Canary Health Service [Cost-effectiveness analysis of prostate cancer screening with prostate-specific antigen associated or not with digital rectal examination in men aged 50 years and older]
2008     Unidad de Evaluacion de Tecnologias Sanitarias (UETS) [Cost-effectiveness analysis of population screening tests for colorectal cancer: systematic review of the efficacy and safety]
2020     Canary Health Service [Cost-effectiveness analysis of newborn screening for severe combined immunodeficiency]
2010     Canary Health Service [Cost-effectiveness analysis of colorectal cancer screening in general population]
2008     Canary Health Service [Cost-effectiveness analysis of breast cancer screening by mammography in different age groups (40-49, 50-69 and 70-75)]
2012     Basque Office for Health Technology Assessment (OSTEBA) [Cost-effectiveness analysis of a telemonitoring experiment in patients with cardiac insufficiency and chronic obstructive pulmonary disease]
2007     Canary Health Service [Cost-effectiveness analysis and health outcomes in orthopedic surgery of the hip and knee]
2023     Center for Outcomes Research and Economic Evaluation for Health (C2H) [Cost-effective analysis evaluation of galcanezumab (Emgality)]
2010     Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) [Cost-benefits evaluation of prevention and control of nosocomial MRSA infections]
2011     Health Intervention and Technology Assessment Program (HITAP) [Cost-benefit analysis of prenatal screening and diagnosis for Down syndrome in Thailand]
2015     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) [Cost studies of type 2 diabetes: a review of literature]
2012     Basque Office for Health Technology Assessment (OSTEBA) [Cost evaluation of the early breast cancer detection programme of the Autonomous Community of the Basque Country]
2008     The Netherlands Organisation for Health Research and Development (ZonMw) [Cost effectiveness of two different implementation procedures to change clinicians practice roles in the detection of hereditary colorectal cancer]
2009     The Netherlands Organisation for Health Research and Development (ZonMw) [Cost effectiveness of scalp cooling in the prevention of chemotherapy-induced hair loss]
2014     Unidad de Evaluacion de Tecnologias Sanitarias (UETS) [Cost effectiveness of different types of coronary stents which are used in patients with acute coronary syndrome (ACS)]
2022     Gesundheit Osterreich GmbH (GOeG) [Cost effectiveness of communication training for health care professionals]
2011     The Netherlands Organisation for Health Research and Development (ZonMw) [Cost effectiveness of a collaborative stepped care intervention for anxiety disorders in the primary care setting]
2015     Basque Office for Health Technology Assessment (OSTEBA) [Cost effective analysis of negative pressure wound therapy for the treatment of venous ulcers in legs]
2014     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Cost and budget impact analysis of an increase in day surgery for selected indications]
2008     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Corticosteroid therapy in the treatment of pediatric patients with atopic dermatitis]
2007     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Corticosteroid therapy in the treatment of pediatric patients with atopic dermatitis]
2013     Basque Office for Health Technology Assessment (OSTEBA) [CORREX® aortic valve bypass for treatment of severe aortic stenosis]
2021     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Coronary lithoplasty for coronary heart disease - Assessment according to §137h Social Code Book V]
2021     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Coronary lithoplasty for coronary heart disease - Addendum to commission H20-07]
2022     Institute for Clinical Effectiveness and Health Policy (IECS) [Coronary intravascular lithotripsy in coronary artery disease]
2001     Finnish Office for Health Care Technology Assessment (Finohta) [Coronary angioplasty in Finland: an overview of the situation in 2000 and an estimation of needs in the near future]
2009     Committee for New Health Technology Assessment (CNHTA) [Corneal cross linking]
2022     Institute for Clinical Effectiveness and Health Policy (IECS) [Corneal collagen crosslinking with riboflavin in keratoconus]
2015     Institute for Clinical Effectiveness and Health Policy (IECS) [Corneal collagen crosslinking with riboflavin for keratoconus patients]
2013     Institute for Clinical Effectiveness and Health Policy (IECS) [Corneal collagen crosslinking for keratoconus patients]
2015     Haute Autorite de sante (HAS) [Corneal collagen cross-linking and intrastromal corneal ring segments in the treatment of corneal ectasia]
2011     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Corifollitropin alfa (Elonva®) for controlled ovarian stimulation in assisted human reproductive techniques]
2024     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Core decompression: Evidence report for the S3 guideline on atraumatic femoral head necrosis in adults]
2021     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Coping strategies in complex medical situations - the example of coronary heart disease]
2008     The Netherlands Organisation for Health Research and Development (ZonMw) [Conventional Or Magnetic resonance angiography after Endovascular Treatment of intracranial aneurysms (COMET)]
2019     Basque Office for Health Technology Assessment (OSTEBA) [Controlled and uncontrolled donation after circulatory death with regional normothermic or hypothermic perfusion based on extracorporeal membrane oxygenation for kidney and liver transplants]
2023     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Contraception: comparison of hormonal coils and copper coils]
2011     Finnish Office for Health Care Technology Assessment (Finohta) [Continuous wound infusion of local anaesthetic agents for postoperative analgesia]
2012     Finnish Office for Health Care Technology Assessment (Finohta) [Continuous subcutaneous insulin infusion in type 1 diabetes mellitus]
2018     Institute for Clinical Effectiveness and Health Policy (IECS) [Continuous subcutaneous infusion pump for diabetic patients]
2013     The Swedish Council on Health Technology Assessment (SBU) [Continuous subcutaneous glucose monitoring for diabetes]
2010     Committee for New Health Technology Assessment (CNHTA) [Continuous local delivery of anesthesia to operative sites using an elastomeric infusion pump]
2015     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Continuous interstitial glucose monitoring (CGM) with real-time measurement devices in insulin-dependent diabetes mellitus]
2010     The Netherlands Organisation for Health Research and Development (ZonMw) [Continuous flow registration for early detection of hepatic artery thrombosis after liver transplantation. Innovative technology reducing retransplantation rate?]
2009     Committee for New Health Technology Assessment (CNHTA) [Continuous femoral nerve block]
2005     Andalusian Health Technology Assessment Area (AETSA) [Continuous blood glucose monitoring system "GlucoWatch"]
2008     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Continuous anaesthetic infusion system at the surgical site]
2021     Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU) [Continuity of care]
2012     Basque Office for Health Technology Assessment (OSTEBA) [Contaminants from the treatment of drinking water in the Autonomous Community of the Basque Country: Assessment of the risk and alternative treatments]
2011     Agenzia nazionale per i servizi sanitari regionali (Agenas) [Consultation on the spread of tele-assistance for the management of the patient in post-stroke rehabilitation]